PRESS RELEASE published on 03/23/2026 at 07:30, 3 months 12 days ago Informations privilégiées / Autres communiqués Sensorion publie les données à six mois de l’essai clinique de Phase 1/2 Audiogene pour SENS-501 et poursuit le développement clinique du GJB2-GT (SENS-601) vers une première administration chez l’homme Essai Clinique Thérapie Génique Sensorion Surdité GJB2-GT
BRIEF published on 03/18/2026 at 07:35, 3 months 17 days ago Sensorion publie ses résultats 2025 et les dernières nouvelles de l'entreprise Résultats Financiers Thérapie Génique Sensorion Perte Auditive Investissements Sanofi
BRIEF published on 03/18/2026 at 07:35, 3 months 17 days ago Sensorion Reports 2025 Results and Corporate Updates Financial Results Gene Therapy Sensorion Hearing Loss Sanofi Investment
PRESS RELEASE published on 03/18/2026 at 07:30, 3 months 17 days ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion publie ses résultats annuels 2025, met à jour sa feuille de route et annonce la publication du rapport annuel, avec des avancées significatives dans les thérapies géniques pour la perte auditive Résultats Annuels Bilan Financier Thérapies Géniques Sensorion Perte Auditive
PRESS RELEASE published on 03/18/2026 at 07:30, 3 months 17 days ago Inside Information / News release on accounts, results Sensorion reports full-year 2025 results, provides corporate update, and announces release of annual report. Key milestones in gene therapies for hearing loss. Financial highlights and future expectations highlighted Financial Highlights Full-year Results Sensorion Gene Therapies Future Milestones
BRIEF published on 02/17/2026 at 07:35, 4 months 15 days ago Sensorion annonce des changements dans sa direction Sensorion Changement Direction Thérapie Auditive Financement Sanofi Pipeline Médical
BRIEF published on 02/17/2026 at 07:35, 4 months 15 days ago Sensorion announces changes in its management Change Of Direction Sensory Auditory Therapy Sanofi Financing Medical Pipeline
BRIEF published on 02/17/2026 at 07:35, 4 months 15 days ago Leadership Transition at Sensorion amid Strategic Focus on Hearing Loss Therapies Biotechnology Gene Therapy Leadership Change Sensorion Hearing Loss
BRIEF published on 02/17/2026 at 07:35, 4 months 15 days ago Transition de direction chez Sensorion dans un contexte de recentrage stratégique sur les thérapies contre la perte auditive Biotechnologie Thérapie Génique Changement De Leadership Sensorion Perte Auditive
PRESS RELEASE published on 02/17/2026 at 07:30, 4 months 15 days ago Informations privilégiées / Autres communiqués Sensorion annonce des changements dans sa direction avec le départ de Nawal Ouzren et la prise de fonction par Amit Munshi en tant que Directeur Général par intérim Direction Sensorion Changements Amit Munshi Nawal Ouzren
Published on 07/03/2026 at 23:00, 16 hours 32 minutes ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 18 hours 4 minutes ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 20 hours 2 minutes ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 1 day 2 hours ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/04/2026 at 11:01, 4 hours 30 minutes ago EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 6 hours 26 minutes ago Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 20 hours 32 minutes ago PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 20 hours 36 minutes ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 18:14, 21 hours 17 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/03/2026 at 21:49, 17 hours 42 minutes ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 17 hours 42 minutes ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 20 hours 49 minutes ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 20 hours 55 minutes ago Disclosure of transactions in own shares from July 1 to July 3, 2026
